- Home
- RVTY vs ICLR Comparison
RVTY vs ICLR Comparison
Compare RVTY & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVTY
- ICLR
- Stock Information
- Founded
- RVTY 1937
- ICLR 1990
- Country
- RVTY United States
- ICLR Ireland
- Employees
- RVTY N/A
- ICLR N/A
- Industry
- RVTY Biotechnology: Laboratory Analytical Instruments
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- RVTY Industrials
- ICLR Health Care
- Exchange
- RVTY Nasdaq
- ICLR Nasdaq
- Market Cap
- RVTY 11.2B
- ICLR 11.5B
- IPO Year
- RVTY N/A
- ICLR 1998
- Fundamental
- Price
- RVTY $91.26
- ICLR $133.96
- Analyst Decision
- RVTY Buy
- ICLR Buy
- Analyst Count
- RVTY 13
- ICLR 12
- Target Price
- RVTY $126.08
- ICLR $206.64
- AVG Volume (30 Days)
- RVTY 1.4M
- ICLR 2.1M
- Earning Date
- RVTY 04-28-2025
- ICLR 04-30-2025
- Dividend Yield
- RVTY 0.31%
- ICLR N/A
- EPS Growth
- RVTY 95.55
- ICLR 11.53
- EPS
- RVTY 2.35
- ICLR 9.19
- Revenue
- RVTY $2,769,868,000.00
- ICLR $8,192,621,999.00
- Revenue This Year
- RVTY $4.83
- ICLR $1.63
- Revenue Next Year
- RVTY $5.99
- ICLR $4.82
- P/E Ratio
- RVTY $39.01
- ICLR $15.07
- Revenue Growth
- RVTY 1.62
- ICLR N/A
- 52 Week Low
- RVTY $89.36
- ICLR $133.28
- 52 Week High
- RVTY $129.50
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- RVTY 40.43
- ICLR 33.96
- Support Level
- RVTY $89.39
- ICLR $135.00
- Resistance Level
- RVTY $94.70
- ICLR $141.96
- Average True Range (ATR)
- RVTY 3.37
- ICLR 6.69
- MACD
- RVTY 0.39
- ICLR 0.43
- Stochastic Oscillator
- RVTY 15.79
- ICLR 3.63
About RVTY Revvity Inc.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.